osimertinib poised to change standard of care treatment for patients with locally advanced egfr-...
Published 2 months ago • 58 plays • Length 2:57Download video MP4
Download video MP3
Similar videos
-
3:31
osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
-
6:50
osimertinib: a potential new standard of care for advanced egfr-mutated nsclc | suresh ramalingam
-
6:28
sequential treatment with afatinib and osimertinib in patients with egfr mutation-positive nsclc
-
1:36
comment: front-line osimertinib significantly lengthens overall survival in egfr-mutation positi...
-
0:48
new standard of care for lung cancer patients with egfr mutations
-
6:08
flaura study: a new standard of care for patients with egfr mutated nsclc
-
16:45
amivantamab in combination with lazertinib for osimertinib-relapsed, chemo-naïve egfrm nsclc
-
53:55
advancing care for patients with egfr mutation–positive nsclc: precision medicine strategies
-
1:02:40
new milestones and changing standards of care in early egfr-mutated nsclc
-
7:11
the changing landscape of first line treatment for egfr mutation-positive nsclc.
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
2:30
tatton: osimertinib plus savolitinib for patients with egfr-mutant, met-amplified nsclc after pr...
-
9:49
osimertinib as frontline therapy for egfr-positive nsclc
-
5:18
frontline therapy for egfr plus nsclc: osimertinib’s impact
-
11:47
osimertinib as first-line treatment for egfr mutation-positive advanced nsclc? (bmic-017)
-
20:18
understanding, preventing, and delaying egfr resistance in the era of osimertinib
-
7:24
2020 ttf egfr session qa panel does progression always occur on osimertinib (tagrisso)?
-
3:31
osimertinib suitable for first line egfrm lung cancer
-
3:22
osimertinib plus chemotherapy shows superior results versus osimertinib alone for egfr-mutated a...